反応式
[C:1]([O:5][C:6]([NH:8][C@H:9]([C:17]([OH:19])=O)[CH2:10][C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C(N1C=CN=C1)(N1C=CN=C1)=O.Cl.[CH3:33][NH:34][O:35][CH3:36].C(N(CC)C(C)C)(C)C>ClCCl>[C:1]([O:5][C:6]([NH:8][C@H:9]([C:17]([N:34]([O:35][CH3:36])[CH3:33])=[O:19])[CH2:10][C:11]1[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=1)=[O:7])([CH3:2])([CH3:3])[CH3:4]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
1000 mg (3.77 mmol) N-(tert-butoxycarbonyl)-L-phenylalanine was placed in 10 mL dichloromethane and mixed with 733 mg (4.52 mmol) 1,1′-carbonyldiimidazole. The batch was stirred for 15 min until the evolution of gas had stopped. Next the mixture was mixed with 441 mg (4.52 mmol) N,O-dimethylhydroxylamine hydrochloride and 657 μL (3.77 mmol) N,N-diisopropylethylamine and stirred for 1 hour at RT. Next the batch was diluted with dichloromethane and washed with distilled water, 0.5N hydrochloric acid and saturated sodium chloride solution in succession. The organic phase was separated and the combined aqueous phases were re-extracted with ethyl acetate. The combined organic phases were dried over magnesium sulfate and concentrated in vacuo, yielding 1090 mg (93% of the theoretical) of the title compound.
後処理
- stirringstirred for 1 hour at RT
- washwashed with distilled water, 0.5N hydrochloric acid and saturated sodium chloride solution in succession
- customThe organic phase was separated
- extractionthe combined aqueous phases were re-extracted with ethyl acetate
- dry with materialThe combined organic phases were dried over magnesium sulfate
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-3f716fca4ead4a42841abe5f54d6c286
- 出典データセット
- uspto-grants-2015_05
- 特許番号
- US09029406B2
関連ノート
読み込み中…